NMRA financials

Neumora Therapeutics (NMRA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

NMRA income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$241.16M-$236.93M-1.45
2024––-$263.46M-$243.79M-1.53
2023––-$252.10M-$235.93M-3.63
2022––-$135.87M-$130.90M-4.81